Ifars Pharmaceutical Laboratories

Ifars Pharmaceutical Laboratories, established in 1974, is a prominent Indonesian pharmaceutical manufacturing company. Operating within the Healthcare and Pharmaceuticals sectors, the company is dedicated to producing high-quality, affordable medicines. Its strategic focus on client health needs has positioned it as a developing name in the regional pharmaceutical landscape. The company's commitment extends to ensuring product safety and efficacy through rigorous pharmacovigilance protocols.

With an employee range of 500 - 1,000 individuals, Ifars Pharmaceutical Laboratories manages significant operational capacity. The company's product portfolio includes a range of medications such as DEVOSIX Drops, FINAZIDE Tablets, VALENIX Gel, and BAXIDERM Salep, developed through its laboratory facilities. This scale of operation and product development is supported by a dedicated team. Meet Ifars Pharmaceutical Laboratories's team to understand the expertise driving their manufacturing and quality assurance processes. The company's presence in Jawa Tengah, Indonesia, underscores its regional operational footprint.

The company's revenue stands at $42.2M, reflecting its market presence and operational scale within the Indonesian pharmaceutical industry. While specific financial details are not accessible via flags, the revenue figure indicates substantial business activity. Ifars Pharmaceutical Laboratories leverages its technical capabilities in pharmaceutical production and laboratory analysis. Hashtags suggest a broad operational scope, including finance, marketing, engineering, and IT, alongside its core medical and health focus. The company's URL, www.ifars.co.id, serves as its primary digital interface.